Kaken Pharmaceutical Co., Ltd.
KKPCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $150,556 | $137,054 | $145,961 | $184,066 |
| - Cash | $54,093 | $50,625 | $59,561 | $61,025 |
| + Debt | $3,850 | $3,850 | $3,850 | $3,850 |
| Enterprise Value | $100,313 | $90,279 | $90,250 | $126,891 |
| Revenue | $94,035 | $72,044 | $72,984 | $76,034 |
| % Growth | 30.5% | -1.3% | -4% | – |
| Gross Profit | $58,532 | $38,539 | $39,556 | $41,576 |
| % Margin | 62.2% | 53.5% | 54.2% | 54.7% |
| EBITDA | $22,017 | $12,566 | $9,402 | $16,384 |
| % Margin | 23.4% | 17.4% | 12.9% | 21.5% |
| Net Income | $13,945 | $8,025 | $5,440 | $9,549 |
| % Margin | 14.8% | 11.1% | 7.5% | 12.6% |
| EPS Diluted | 365.42 | 212.66 | 144.79 | 251.44 |
| % Growth | 71.8% | 46.9% | -42.4% | – |
| Operating Cash Flow | $29,780 | $2,577 | $9,253 | $13,336 |
| Capital Expenditures | -$4,392 | -$2,167 | -$2,206 | -$3,257 |
| Free Cash Flow | $25,388 | $410 | $7,047 | $10,079 |